VPM serves as a think-tank, and includes a world-leading faculty of scientists, clinical opinion leaders, industry experts and decision-makers. It is a unique opportunity for networking and exchanging knowledge, skills and experiences in the field of ischaemic heart disease.
A multitude of technical advances and clinical trials in the field were conceived at this meeting. The programme addresses the state-of-the-art developments in the fundamental mechanisms of atherosclerosis, technical advances in the diagnosis and risk stratification of the disease, as well as the most recent developments in clinical trials. There are always extensive discussions on future research directions.
The meeting faculty consists of nearly 80 internationally renowned researchers, as well as key industry partners that were invited to participate in discussions and contribute to advancing the field.
Please register for online access to the meeting.
Programme overview
DAY 3
- Pre-emptive treatment of vulnerable plaques to improve clinical outcomes
- Novel local treatment modalities for vulnerable plaques
- Intracoronary imaging to guide local interventional treatment – choosing where and how to treat
- Innovations in telemedicine in coronary syndromes
- Refractory angina: thinking beyond the epicardial coronary arteries – mechanisms, diagnosis and treatment
- Novel pharmacologic options to improve cardiovascular outcomes in atherosclerotic disease
